<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NovaBone &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/novabone/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Fri, 22 Aug 2025 14:31:40 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>NovaBone &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>NovaBone To Unveil First-of-Its-Kind Bioactive Wedge at AOFAS 2025 Annual Meeting in Savannah (PR Newswire)</title>
		<link>https://innovate.research.ufl.edu/novabone-to-unveil-first-of-its-kind-bioactive-wedge-at-aofas-2025-annual-meeting-in-savannah/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Fri, 22 Aug 2025 14:06:48 +0000</pubDate>
				<category><![CDATA[Accelerate]]></category>
		<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[American Orthopaedic Foot & Ankle Society]]></category>
		<category><![CDATA[AOFAS]]></category>
		<category><![CDATA[NovaBone]]></category>
		<category><![CDATA[synthetic bone graft technologies]]></category>
		<category><![CDATA[UF startup]]></category>
		<guid isPermaLink="false">https://innovate.research.ufl.edu/?p=19479</guid>

					<description><![CDATA[UF startup NovaBone, a pioneer in synthetic bone graft technologies, will showcase its Bioactive Pre-contoured Wedge (BPW) at the 2025 American Orthopaedic Foot &#038; Ankle Society (AOFAS) Annual Meeting.]]></description>
										<content:encoded><![CDATA[<p>UF startup NovaBone, a pioneer in synthetic bone graft technologies, will showcase its groundbreaking Bioactive Pre-contoured Wedge (BPW) at the 2025 American Orthopaedic Foot &amp; Ankle Society (AOFAS) Annual Meeting in <span class="xn-location">Savannah, Georgia</span>.</p>
<p>The Bioactive Pre-contoured Wedge is the first fully-synthetic, porous bioactive glass solution to come to market and is, specifically, designed with osteostimulation in mind. BPW is the first non-metal wedge that is classified as a device, prioritizing patient safety and intra-operative effectiveness. It is engineered to correct deformities and fill osseous defects, while providing a fully resorbable, bio-integrative scaffold that promotes and accelerates bone regeneration.</p>
<p>&nbsp;</p>
<p>Read more about <a href="http://prnewswire.com/news-releases/novabone-to-unveil-first-of-its-kind-bioactive-wedge-at-aofas-2025-annual-meeting-in-savannah-302536000.html">NovaBone To Unveil First-of-Its-Kind Bioactive Wedge at AOFAS 2025 Annual Meeting in Savannah.</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.</title>
		<link>https://innovate.research.ufl.edu/novabone-partnership-with-summit-products/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Wed, 07 May 2025 00:00:00 +0000</pubDate>
				<category><![CDATA[Accelerate]]></category>
		<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[NovaBone]]></category>
		<category><![CDATA[Novabone Products]]></category>
		<category><![CDATA[NovaForm]]></category>
		<category><![CDATA[NovaForm® Wound Matrix]]></category>
		<category><![CDATA[Summit Products Group]]></category>
		<category><![CDATA[UF startup]]></category>
		<guid isPermaLink="false">https://scaddev1.com/novabone-partnership-with-summit-products/</guid>

					<description><![CDATA[UF startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with Summit Products Group, a national provider of advanced wound care solutions. ]]></description>
										<content:encoded><![CDATA[
<p>UF startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with <a href="https://totalancillary.com/" target="_blank" rel="noreferrer noopener">Summit Products Group</a>, a national provider of advanced wound care solutions. Under this agreement, Summit Products Group will serve as a key distributor of NovaForm<sup>®</sup> Wound Matrix, NovaBone’s collagen-based wound dressing recently cleared by the FDA.</p>



<p>The partnership marks a significant milestone in NovaBone’s expansion into the advanced wound care market. Summit Products Group’s deep distribution network and strong presence in post-acute and outpatient care settings will support the rapid adoption and accessibility of NovaForm<sup>®</sup>&nbsp;across the United States.</p>



Read more about <a href="https://world.einnews.com/pr_news/809954373/novabone-announces-strategic-partnership-with-summit-products-group-to-distribute-novaform-wound-matrix-in-the-u-s"> NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.</a>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications</title>
		<link>https://innovate.research.ufl.edu/novabone-putty-fda-clearance/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[Tech Licensing]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[fda clearance]]></category>
		<category><![CDATA[NovaBone]]></category>
		<category><![CDATA[Novabone Products]]></category>
		<category><![CDATA[NovaBone Putty]]></category>
		<category><![CDATA[UF startup]]></category>
		<guid isPermaLink="false">https://scaddev1.com/novabone-putty-fda-clearance/</guid>

					<description><![CDATA[UF Startup NovaBone Products announced that it has received FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, which is now expandable for use in the intervertebral disc space.]]></description>
										<content:encoded><![CDATA[
<p>NovaBone Products, a UF Startup and a leader in synthetic bone graft solutions, has announced its latest milestone: FDA clearance for its bioactive synthetic bone graft, NovaBone Putty, now expanded for use in the intervertebral disc space. This clearance marks an important addition to NovaBone’s existing portfolio, extending the use of NovaBone Putty for interbody fusion procedures to support a broader range of spinal and orthopedic surgical needs.</p>



Read more about <a href="https://www.entrepreneurshipreporter.com/article/759924959-novabone-secures-fda-clearance-for-expanded-indications-of-putty-in-interbody-fusion-applications"> NovaBone Secures FDA Clearance for Expanded Indications of Putty in Interbody Fusion Applications.</a>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Collagen Solutions Enters Into Three-Year New Agreement With NovaBone Products</title>
		<link>https://innovate.research.ufl.edu/collagen-solutions-enters-into-three-year-new-agreement-with-novabone-products/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Thu, 09 Jul 2020 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF Startup]]></category>
		<category><![CDATA[NovaBone]]></category>
		<guid isPermaLink="false">https://scaddev1.com/collagen-solutions-enters-into-three-year-new-agreement-with-novabone-products/</guid>

					<description><![CDATA[Collagen Solutions, a company producing custom formulations of medical-grade collagen biomaterials and tissues for use in medical devices, had entered into a new minimum three-year agreement with UF startup NovaBone Products, a designer and manufacturer of synthetic bone grafts. The agreement formalized a longer-term supply arrangement to ensure NovaBone had consistent and increased access to this [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p><a href="https://www.collagensolutions.com/">Collagen Solutions</a>, a company producing custom formulations of medical-grade collagen biomaterials and tissues for use in medical devices, had entered into a new minimum three-year agreement with UF startup <a href="https://novabone.com/">NovaBone Products</a>, a designer and manufacturer of synthetic bone grafts.</p>



<p>The agreement formalized a longer-term supply arrangement to ensure  NovaBone had consistent and increased access to this specialized material to support their continued growth.</p>



Learn more about <a href="https://www.stockmarketwire.com/article/6992733/Collagen-Solutions-enters-into-three-year-new-agreement-with-NovaBone-Products.html">Collagen Solutions Enters Into Three-Year New Agreement With NovaBone Products.</a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
